A specialty pharmaceutical company focused on treatments for opioid use disorder and other substance-use and mental-health conditions, including its Suboxone and Sublocade products.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| George Soros / Soros Fund Mgmt | 30 | New buy | 1,353,865 | $32,641,685 | 0.5% |
| Howard Marks / Oaktree | 69 | Added +2242% | 257,785,398 | $10,692,053 | 0.2% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.